The Hidden Risk of Full-Body Scans: False Positives, Incidentalomas and Medical Anxiety (2026)

Featured image for The Hidden Risk of Full-Body Scans: False Positives, Incidentalomas and Medical Anxiety (2026)

The biggest risk of full-body scans in healthy people isn't the scan itself — it's what it finds. In low-risk, asymptomatic people, a sensitive whole-body scan very often finds "something", but most of those findings are benign or clinically meaningless. Chasing them leads to repeat imaging, blood tests, referrals, biopsies, anxiety and overdiagnosis. This is why major radiology bodies, including the American College of Radiology, do not recommend total-body screening for people without symptoms, risk factors or a relevant family history. The Midjourney scanner has revived this debate; the evidence behind it is well established.

Key takeaways

  • In asymptomatic people, whole-body scans find many abnormalities — most benign or insignificant.
  • Confirmed cancer detection in asymptomatic screening runs at roughly 1.1–1.5%, with far more false alarms.
  • Incidental findings drive a cascade of tests, biopsies (mostly negative), cost and anxiety.
  • Screening is not diagnosis: it needs evidence of net benefit, defined populations and follow-up pathways.
  • Removing radiation (as ultrasound does) lowers one harm but doesn't fix overdiagnosis.

What's the actual problem with scanning healthy people?

A scan sensitive enough to catch early disease is also sensitive enough to catch a great deal that doesn't matter. In a symptomatic patient, findings are interpreted against a clinical question. In a healthy person with no symptoms, every finding has to be evaluated on its own — including the benign variations that would otherwise never have been noticed. The result is a high yield of abnormalities and a low yield of abnormalities that actually change outcomes.

What is an incidentaloma?

An incidentaloma is an unexpected finding picked up by a scan done for another reason (or for no specific reason at all) — a thyroid nodule, a small kidney cyst, a liver lesion, an indeterminate lymph node. Many are completely harmless. The difficulty is that, once seen, a finding usually can't be un-seen: it has to be explained, often with more tests, even when the most likely answer is "nothing".

What are the downstream harms?

The harm is rarely the first scan — it's the cascade that follows:

  • Repeat and more detailed imaging to characterise a finding.
  • Blood tests and specialist referrals.
  • Biopsies and procedures, with their own risks — most of which, in screening populations, come back negative.
  • Anxiety and the psychological burden of becoming a "patient" overnight.
  • Opportunity cost: clinician time and scarce capacity diverted from people who are actually unwell.

The numbers tell the story. Systematic reviews of whole-body MRI in asymptomatic people report confirmed cancer detection of roughly 1.1–1.5%, alongside a substantial volume of abnormal findings, most of them benign. Studies have shown that disclosing incidental findings increases biopsies — the majority of which find nothing.

Screening versus diagnosis

This is the distinction consumer scanning blurs. A diagnostic test answers a question raised by symptoms. A screening programme is a population-level intervention that must clear a higher bar: evidence of net benefit, a defined target population, a clear follow-up pathway, and outcome data showing it does more good than harm. A consumer scan sold without any of that produces ambiguous information, not better health. As the American College of Radiology puts it, there is insufficient evidence to recommend total-body screening in people without symptoms, risk factors or relevant family history, and no documented evidence it prolongs life — but a real risk of non-specific findings leading to unnecessary follow-up.

Does removing radiation change the calculus?

Partly, and it's worth being fair about it. Midjourney's scanner uses ultrasound, so it avoids the ionising radiation of CT — removing one genuine harm of some whole-body screening. But radiation was never the main argument against screening healthy people. The incidentaloma, false-positive and overdiagnosis problems are independent of the modality, and a device explicitly designed for casual, high-volume, "whenever you want" scanning could amplify them rather than reduce them. No radiation is good; no clear follow-up pathway is still the core problem.

The clinician takeaway

More data is not automatically better medicine. The value of any test comes from context, risk stratification and evidence-based next steps — not from the sheer volume of findings it generates. As consumer scans spread, clinicians will increasingly be handed reports of incidental findings and asked, "Is this serious?" The practical task is to map each finding to recognised guidance and avoid reflexive over-investigation. A guideline-grounded reference helps here: Ask iatroX is free and lets clinicians check what NICE, CKS, SIGN or the SmPC recommend for a given incidental finding — supporting a measured, evidence-based response rather than an anxious one. This is a sensitive area, so if a scan or its findings are causing you distress, speak to your own clinician.

Frequently asked questions

Are full-body scans safe for healthy people? The scan itself may carry little direct risk (especially radiation-free ultrasound), but the findings often trigger a cascade of further tests, biopsies and anxiety. Major radiology bodies advise against routine total-body screening in asymptomatic people.

What is an incidentaloma? An unexpected, often harmless finding picked up incidentally on a scan — such as a thyroid nodule, kidney cyst or liver lesion — that then has to be explained, frequently with more testing.

How often do full-body scans find cancer in healthy people? Confirmed cancer detection in asymptomatic screening is roughly 1.1–1.5%, while a much larger number of abnormal findings turn out to be benign — so the false-alarm rate is high relative to true positives.

Why do doctors worry about preventive whole-body scans? Because in low-risk people they generate many findings that don't improve health but do drive unnecessary tests, procedures, cost and anxiety — and there's no evidence they prolong life.

Does Midjourney's radiation-free scanner avoid these problems? It avoids radiation, which is a real benefit, but not the overdiagnosis and incidental-finding problems, which depend on screening healthy people rather than on the type of scan.

Share this insight